These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tetraspanin 1 inhibits TNFα-induced apoptosis via NF-κB signaling pathway in alveolar epithelial cells. Yang L; Wang Y; Pan Z; Gao S; Zou B; Lin Z; Feng D; HuangFu C; Liu G Inflamm Res; 2018 Dec; 67(11-12):951-964. PubMed ID: 30291375 [TBL] [Abstract][Full Text] [Related]
23. Dach1 deficiency drives alveolar epithelium apoptosis in pulmonary fibrosis via modulating C-Jun/Bim activity. Lu Y; Tang K; Wang S; Tian Z; Fan Y; Li B; Wang M; Zhao J; Xie J Transl Res; 2023 Jul; 257():54-65. PubMed ID: 36754276 [TBL] [Abstract][Full Text] [Related]
24. The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling. Zhang J; Zhang Y; Chen Q; Qi Y; Zhang X Int Immunopharmacol; 2024 Mar; 130():111734. PubMed ID: 38422768 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts. Yang J; Pan X; Xu M; Li Y; Liang C; Liu L; Li Z; Wang L; Yu G Respir Res; 2024 Apr; 25(1):176. PubMed ID: 38658970 [TBL] [Abstract][Full Text] [Related]
26. Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis. Wu W; Wu X; Qiu L; Wan R; Zhu X; Chen S; Yang X; Liu X; Wu J Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4809-4822. PubMed ID: 38153514 [TBL] [Abstract][Full Text] [Related]
27. TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis. Chen H; He A; Li H; Chen H; Xie H; Luo L; Huang Y; Chen J; Guan J; He Q; Ma J; Ou C; Tao A; Yan J Cell Death Dis; 2021 Oct; 12(10):938. PubMed ID: 34645797 [TBL] [Abstract][Full Text] [Related]
28. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
29. Ephedrine alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and restraining NF-κB signaling. Tian H; Wang L; Fu T J Toxicol Sci; 2023; 48(10):547-556. PubMed ID: 37778983 [TBL] [Abstract][Full Text] [Related]
31. FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model. Lv YQ; Cai GF; Zeng PP; Dhlamini Q; Chen LF; Chen JJ; Lyu HD; Mossahebi-Mohammadi M; Ahmadvand N; Bellusci S; Li X; Chen C; Zhang JS Cells; 2022 Aug; 11(15):. PubMed ID: 35954241 [TBL] [Abstract][Full Text] [Related]
32. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237 [TBL] [Abstract][Full Text] [Related]
33. NMDA receptor activation inhibits the protective effect of BM‑MSCs on bleomycin‑induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF. Peng X; Li X; Li C; Yue S; Huang Y; Huang P; Cheng H; Zhou Y; Tang Y; Liu W; Feng D; Luo Z Int J Mol Med; 2019 Jul; 44(1):227-239. PubMed ID: 31115492 [TBL] [Abstract][Full Text] [Related]
34. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats. Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439 [TBL] [Abstract][Full Text] [Related]
35. Susceptibility of microtubule Kesireddy VS; Chillappagari S; Ahuja S; Knudsen L; Henneke I; Graumann J; Meiners S; Ochs M; Ruppert C; Korfei M; Seeger W; Mahavadi P FASEB J; 2019 Nov; 33(11):12392-12408. PubMed ID: 31431059 [TBL] [Abstract][Full Text] [Related]
36. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
37. [Effect of small dose capsaicin for treatment of pulmonary fibrosis in mice and its mechanism]. Lu LM; Yu TT; He XW; Tang J; Li XW Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 May; 36(3):216-222. PubMed ID: 32981275 [No Abstract] [Full Text] [Related]
38. Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation. Yan B; Ma Z; Shi S; Hu Y; Ma T; Rong G; Yang J Mol Med Rep; 2017 Jun; 15(6):4005-4014. PubMed ID: 28487960 [TBL] [Abstract][Full Text] [Related]
39. Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells. Duan JX; Guan XX; Yang HH; Mei WX; Chen P; Tao JH; Li Q; Zhou Y Int Immunopharmacol; 2021 Dec; 101(Pt B):108211. PubMed ID: 34634687 [TBL] [Abstract][Full Text] [Related]
40. BMSCs promote alveolar epithelial cell autophagy to reduce pulmonary fibrosis by inhibiting core fucosylation modifications. Hu J; Wang N; Jiang Y; Li Y; Qin B; Wang Z; Gao L Stem Cells; 2024 Sep; 42(9):809-820. PubMed ID: 38982795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]